When to stop non-selective beta-blockers: the window hypothesis in clinical practice Reply

被引：0
作者：
Krag, Aleksander [1 ,2 ]
Gluud, Lise Lotte [3 ]
机构：
[1] Univ Southern Denmark, Dept Gastroenterol & Hepatol, Odense, Denmark
[2] Odense Univ Hosp, DK-5000 Odense, Denmark
[3] Copenhagen Univ Hosp, Dept Gastroenterol, Hvidovre, Denmark
来源：
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES | 2014年 / 23卷 / 04期
关键词：
CIRRHOSIS; SURVIVAL;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：458 / 458
页数：1
相关论文
共 28 条
  • [21] Clinical Impact of Selective and Nonselective Beta-Blockers on Survival in Patients With Ovarian Cancer
    Watkins, Jack L.
    Thaker, Premal H.
    Nick, Alpa M.
    Ramondetta, Lois M.
    Kumar, Sanjeev
    Urbauer, Diana L.
    Matsuo, Koji
    Squires, Kathryn C.
    Coleman, Robert L.
    Lutgendorf, Susan K.
    Ramirez, Pedro T.
    Sood, Anil K.
    CANCER, 2015, 121 (19) : 3444 - 3451
  • [22] Non-selective beta-blockers increase overall and liver mortality in alcoholic cirrhosis with MELD ≥ 12 over 5 years of follow-up
    Cales, Paul
    Bertrais, Sandrine
    Boursier, Jerome
    Fouchard, Isabelle
    Oberti, Frederic
    LIVER INTERNATIONAL, 2021, 41 (01) : 168 - 179
  • [23] Comparative efficacy of endoscopic variceal ligation versus non-selective beta-blockers in primary prevention of gastroesophageal varix type 2: an IPTW-adjusted study
    Liu, Linxiang
    Ye, Shenfeng
    Nie, Yuan
    Zhu, Xuan
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2025, 39 (01): : 332 - 340
  • [24] Non-Selective Beta-Blockers Decrease Infection, Acute Kidney Injury Episodes, and Ameliorate Sarcopenic Changes in Patients with Cirrhosis: A Propensity-Score Matching Tertiary-Center Cohort Study
    Li, Tzu-Hao
    Liu, Chih-Wei
    Huang, Chia-Chang
    Tsai, Yu-Lien
    Huang, Shiang-Fen
    Yang, Ying-Ying
    Tsai, Chang-Youh
    Hou, Ming-Chih
    Lin, Han-Chieh
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [25] Impact of non-selective beta blockers on further decompensation and death in decompensated cirrhosis: Benefit and risk stratification by MELD score
    Wang, Ting
    Wang, Xueying
    Jia, Siqi
    Zhao, Haitao
    Wang, Le
    Zhang, Xianxian
    Fang, Xiaohui
    He, Yong
    Li, Hongyu
    Tacke, Frank
    Qi, Xingshun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (10) : 1409 - 1420
  • [26] Non selective beta-blockers prevent PHT-related complications occurrence in HCC patients with esophageal varices treated by TACE
    Allaire, Manon
    Garcia, Helene
    Meyblum, Louis
    Mouri, Sarah
    Spitzer, Eleonore
    Goumard, Claire
    Lucidarme, Olivier
    Rudler, Marika
    Scatton, Olivier
    Roux, Charles
    Wagner, Mathilde
    Thabut, Dominique
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2025, 49 (01)
  • [27] Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure
    Mookerjee, Rajeshwar P.
    Pavesi, Marco
    Thomsen, Karen Louise
    Mehta, Gautam
    Macnaughtan, Jane
    Bendtsen, Flemming
    Coenraad, Minneke
    Sperl, Jan
    Gines, Pere
    Moreau, Richard
    Arroyo, Vicente
    Jalan, Rajiv
    JOURNAL OF HEPATOLOGY, 2016, 64 (03) : 574 - 582
  • [28] Dose optimization of non-selective beta blockers among esophageal varices patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a hospital-based cross-sectional study
    Alemu, Getachew Sahile
    Mengistu, Segenet Bizuneh
    Gedamu, Yonas
    Ayele, Eleni
    Admas, Hiwot Alemu
    Melese, Endalkachew Belayneh
    Ayalew, Desalew Getahun
    Legese, Gebrehiwot Lema
    BMC GASTROENTEROLOGY, 2025, 25 (01)
123